Cell and gene therapy innovators and other stakeholders across the supply chain need to set themselves up for the greatest chance of success by addressing three key challenges: access barriers ...

Experts from Cerba Research, a leading specialty laboratory solutions provider, recently attended the 31 st European Society of Gene and Cell Therapy (ESGCT) Congress to share some of its most recent ...

The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

In addition, there are companies developing cell and gene therapy supply chain software to allow the drug developers and CROs to manage the supply chains. With rapidly evolving cell and gene ...

McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Pharmaceutical supply chains are some of the world ... industry are poised for significant growth. The cell and gene therapy (CGT) market is expected to expand at a rapid pace, with a projected ...

Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the journal Human Gene ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech Global Forum in London, UK. Since its ...

China has pledged to encourage more research in gene and cell therapies at the country’s biotech hub in the eastern Chinese ...

Temperature-controlled supply chain solutions firm Cryoport ... viral vectors, and gene therapies in perfect condition.